Immunomedics Inc (NASDAQ:IMMU)

16.59
Delayed Data
As of Sep 20
 -0.46 / -2.70%
Today’s Change
11.55
Today|||52-Week Range
24.99
+16.26%
Year-to-Date

Today’s Trading

Previous close17.05
Today’s open17.01
Day’s range16.06 - 17.25
Volume6,222,395
Average volume (3 months)2,338,250
Market cap$3.2B
Data as of 4:00pm ET, 09/20/2019

Growth & Valuation

Earnings growth (last year)-13.77%
Earnings growth (this year)+9.10%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)-100.00%
P/E ratioNM
Price/Sales--
Price/Book11.94

Competitors

 Today’s
change
Today’s
% change
NKTRNektar Therapeutics-0.07-0.35%
TLRYTilray Inc-0.96-3.20%
MORMorphoSys AG-0.05-0.17%
ARWRArrowhead Pharmaceut...-0.23-0.79%
Data as of 4:00pm ET, 09/20/2019

Financials

Next reporting dateNovember 7, 2019
EPS forecast (this quarter)-$0.37
Annual revenue (last year)$0.00
Annual profit (last year)-$157.7M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Financial &
Business Officer
Usama Malik
Chief Technology Officer
Morris Z. Rosenberg
Corporate headquarters
Morris Plains, New Jersey

Forecasts